GRI Bio share price logo

GRI Bio

NASDAQ: GRI

$1.88

+0.33

(+21.29%)

as on

GRI Bio Stock Performance

as on November 7, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.61
    $1.94
    downward going graph

    14.36%

    Downside

    3.19%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.36
    $64.12
    downward going graph

    27.66%

    Downside

    3310.64%

    Upside

    downward going graph

GRI Bio share price movements today

Previous Close
$1.55
Open
$1.61
Volume
675.7K
Market Cap
$3.4M
Day's Low - High
$1.61 - $1.94
52 Week Low - High
$1.36 - $64.12

GRI Bio Historical Returns

1 Month Return
+ 1.62 %
3 Month Return
+ 27.89 %
1 Year Return
-96 %
3 Year Return
-100 %
5 Year Return
0 %

GRI Bio Stock Fundamentals & Key Indicators

Check GRI Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.4M

EPS (TTM)

-80.38

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.04

Industry PE ratio

-3.22

PEG Ratio

-0.00

EBITDA

-12.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-134.03%

GRI Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of GRI Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$3.4MNA-0.040.00%0.00%
Neutral$96.4B7.26%-30.26-12.57%0.00%
StrongBuy$137.5B183.69%34.6485.57%0.00%
Buy$96.3B47.88%19.2385.77%0.41%

Stock Returns calculator for GRI Bio Stock including INR - Dollar returns

The GRI Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 7Y

  • 10Y

GRI Bio investment value today

Current value as on today

₹4,233

Returns

-₹95,767

(-95.77%)

Returns from GRI Bio Stock

-₹96,003 (-96%)

Dollar Impact

₹236 (+0.24%)

Analyst Recommendation on GRI Bio Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for GRI Bio. Average target price of $18.5

GRI Bio Share Price Target

Get share price movements and forecasts by analysts on GRI Bio.

What analysts predicted

89.84%UPSIDE

Target Price

$18.5

Current Price

$1.88

Analyzed by

5 Analysts

Target

$18.50

GRI Bio target price $18.5, a slight upside of 89.84% compared to current price of $1.88. According to 5 analysts rating.

Indian Investors' Interest in GRI Bio Stock

Search interest for GRI Bio Stock has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-82% versus previous 30 day period

GRI Bio Quarterly Profit & Loss

All numbers in Millions USD

Apr 2024
Jun 2024
Oct 2024
Dec 2024
Mar 2025
Jun 2025
Oct 2025
Jan 2026
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
0
0
-
Operating Income
-1
-2
-2
-1
-3
-2
-3
-2
-2
-1
EBITDA
-1
-2
-2
-1
-3
-2
-3
-2
-2
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-1
-2
-2
-1
-3
-2
-3
-2
-1
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-2
-2
-1
-3
-2
-3
-2
-1
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

GRI Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
-
0
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
0
Operating Income
-4
-3
-1
-1
-2
-11
-8
-11
EBITDA
-4
-3
-1
0
-2
-10
-8
-11
Interest Expense
-
0
0
0
0
2
-
-
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-4
-3
-2
-1
-3
-13
-8
-11
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-4
-3
-2
-1
-3
-13
-8
-11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-0.02%
0.00%

GRI Bio Quarterly Cash Flow

All numbers in Millions USD

Apr 2024
Jun 2024
Oct 2024
Dec 2024
Mar 2025
Jun 2025
Oct 2025
Jan 2026
Mar 2026
Jun 2026
Net Income
-1
-2
-2
-1
-3
-2
-3
-2
-1
-1
Operating Cash Flow
-2
-2
-2
-1
-1
-3
-2
-2
-3
-1
Investing Cash Flow
-
-
-
-
-
-
-
0
-
-
Financing Cash Flow
4
4
0
2
0
5
1
7
6
1
Change in Cash
2
2
-1
0
-1
1
-1
4
2
0

GRI Bio Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
-4
-3
-4
-9
-3
-13
-8
-11
Operating Cash Flow
-2
-2
-3
-8
-1
-8
-8
-10
Investing Cash Flow
0
-
0
-3
0
0
-
0
Financing Cash Flow
2
6
0
15
1
10
11
13
Change in Cash
0
3
-3
3
0
1
3
3

Global Institutional Holdings in GRI Bio

Check out the Institutions with significant holdings in GRI Bio.

Funds
Holdings
VANGUARD INDEX FUNDS
0.98%
Vanguard
0.98%
Fidelity Concord Street Trust
0.46%
BlackRock, Inc.
0.00%

GRI Bio News & Key Events

  • img

    Today's Timeline - 08 September

    Tue, 06:17 PM

    -

    GRI Bio reports positive Phase 2a biomarker data for GRI-0621, showing reduced cough and diarrhea compared to placebo.

Insights on GRI Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, GRI stock has moved up by 22.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 935.8% return, outperforming this stock by 1031.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 245.1% return, outperforming this stock by 345.1%

About GRI Bio

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company’s portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. The company was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
OrganisationGRI Bio
Headquarters2223 Avenida de la Playa, La Jolla, CA, 92037, US
IndustryBiotechnology
CEOW. Marc Hertz

Key Management of GRI Bio

Name

Title

Dr. Vipin Kumar Chaturvedi Ph.D.

Co-Founder & Chief Scientific Officer

Ms. Leanne M. Kelly

CFO & Corporate Secretary

Dr. Albert Agro Ph.D.

Co-Founder & Chief Medical Officer

Dr. W. Marc Hertz Ph.D.

Co-Founder, CEO, President & Director

FAQs

What is GRI Bio share price today?

GRI Bio share price today is $1.88 as on at the close of the market. GRI Bio share today touched a day high of $1.94 and a low of $1.61.

What is the 52 week high and 52 week low for GRI Bio share?

GRI Bio share touched a 52 week high of $64.12 on and a 52 week low of $1.36 on . GRI Bio stock price today i.e. is closed at $1.88,which is 97.07% down from its 52 week high and 38.24% up from its 52 week low.

What is GRI Bio's market capitalisation today?

GRI Bio market capitalisation is $0.00T as on .

How to invest in GRI Bio Stock (GRI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for GRI Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy GRI Bio Stock (GRI) from India?

Indian investors can start investing in GRI Bio (GRI) shares with as little as ₹93.91000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in GRI Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on GRI Bio share’s latest price of $1.88 as on November 7, 2026 at 8:45 am IST, you will get 5.3191 shares of GRI Bio. Learn more about fractional shares .